Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ferro

Showing results (71-80 of 403) with videos related to

Pageof 41
Sort By:
Plant Physiology|October 1, 1983
Intermediates in the recycling of 5-methylthioribose to methionine in fruitsM M Kushad, D G Richardson, A J Ferro
Clinical Kidney Journal|May 2, 2022
Blood pressure targets in CKD 2021: the never-ending guidelines debacleSol Carriazo, Pantelis Sarafidis, Charles J Ferro, et al.
Journal of Bacteriology|January 1, 1978
Relationship between polyamines and macromolecules in germinating yeast ascosporesS J Choih, A J Ferro, S K Shapiro
Journal of Human Hypertension|March 3, 2021
Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunctionCharalampos Loutradis, Anna Price, Charles J Ferro, et al.
Biochimica Et Biophysica Acta|June 2, 1983
The comparative effects of 5'-methylthioadenosine and some of its analogs on cells containing, and deficient in, 5'-methylthioadenosine phosphorylaseM W White, M K Riscoe, A J Ferro
Biochemical and Biophysical Research Communications|May 29, 1981
Inactivation of S-adenosylhomocysteine hydrolase by 5'-deoxy-5'-methylthioadenosineA J Ferro, A A Vandenbark, M R MacDonald
Biochimica Et Biophysica Acta|January 17, 1980
The stimulatory effect of testosterone propionate and 17 beta-estradiol on 5'-methylthioadenosine phosphorylase activity in rat target tissuesJ A Nicolette, N C Wrobel, A J Ferro
Biochemical and Biophysical Research Communications|September 16, 1982
5-Methylthioribose kinase activity in plantsM M Kushad, D G Richardson, A J Ferro
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 DiabetesNicola C Edwards, Charles J Ferro, Jonathan N Townend
The New England Journal of Medicine|August 8, 1998
Bosentan in essential hypertensionW G Haynes, C J Ferro, D J Webb
Pageof 41

Showing results (71-80 of 403) with videos related to

Sort By:
Pageof 41
Plant Physiology|October 1, 1983
Intermediates in the recycling of 5-methylthioribose to methionine in fruitsM M Kushad, D G Richardson, A J Ferro
Clinical Kidney Journal|May 2, 2022
Blood pressure targets in CKD 2021: the never-ending guidelines debacleSol Carriazo, Pantelis Sarafidis, Charles J Ferro, et al.
Journal of Bacteriology|January 1, 1978
Relationship between polyamines and macromolecules in germinating yeast ascosporesS J Choih, A J Ferro, S K Shapiro
Journal of Human Hypertension|March 3, 2021
Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunctionCharalampos Loutradis, Anna Price, Charles J Ferro, et al.
Biochimica Et Biophysica Acta|June 2, 1983
The comparative effects of 5'-methylthioadenosine and some of its analogs on cells containing, and deficient in, 5'-methylthioadenosine phosphorylaseM W White, M K Riscoe, A J Ferro
Biochemical and Biophysical Research Communications|May 29, 1981
Inactivation of S-adenosylhomocysteine hydrolase by 5'-deoxy-5'-methylthioadenosineA J Ferro, A A Vandenbark, M R MacDonald
Biochimica Et Biophysica Acta|January 17, 1980
The stimulatory effect of testosterone propionate and 17 beta-estradiol on 5'-methylthioadenosine phosphorylase activity in rat target tissuesJ A Nicolette, N C Wrobel, A J Ferro
Biochemical and Biophysical Research Communications|September 16, 1982
5-Methylthioribose kinase activity in plantsM M Kushad, D G Richardson, A J Ferro
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 DiabetesNicola C Edwards, Charles J Ferro, Jonathan N Townend
The New England Journal of Medicine|August 8, 1998
Bosentan in essential hypertensionW G Haynes, C J Ferro, D J Webb
Pageof 41